Silhouette Instalift

ABSORBABLE SUTURES

THE FIRST ABSORBABLE SUTURE FDA-CLEARED FOR COSMETIC FACIAL PROCEDURES

NON-SURGICAL, IMMEDIATE AND LASTING LIFT

Silhouette InstaLift® is the only non-surgical rejuvenating procedure that uses advanced Micro-Suspension Technology™ to offer immediate and lasting results.*

MINIMAL DOWNTIME, LONG LASTING RESULTS

The procedure only takes under an hour and is done right in your doctor’s office. InstaLift also has minimal downtime with most signs of treatment (ex: bruising, swelling, and tenderness at the treatment site) dissipating within 24–48 hours. Patients can get right back to their activities and enjoy an instant lift in the cheeks, while adding volume over time for long lasting results.

 

MICRO SUSPENSION TECHNOLOGY™

Silhouette InstaLift® is a treatment unlike any other. Our Micro Suspension Technology™ is comprised of micro cones that are placed in the deepest layer of mid-facial skin. It delivers an immediate lift and gradually restores lost facial volume of the mid face by activating your own natural collagen production for a more youthful appearance that continues to improve over time. The sutures and cones are made from poly lactic-co-glycolic acid (PLGA), a well-known biomedical copolymer that is biocompatible and biodegradable 1,2,†

TREATMENT RESULTS

BEFORE AND AFTERS

MODEL IS A REAL PATIENT TREATED WITH SILHOUETTE INSTALIFT BY YAEL HALAAS, MD. INDIVIDUAL TECHNIQUE AND RESULTS MAY VARY
MODEL IS A REAL PATIENT TREATED WITH SILHOUETTE INSTALIFT BY ELLEN TURNER, MD. INDIVIDUAL TECHNIQUE AND RESULTS MAY VARY

 

WHITE PAPERS

Expert Consensus on Absorbable Advanced Suspension
Technology for Facial Tissue Repositioning and Volume
Enhancement and Straight-Line Vector Planning for
Optimal Results With

DOWNLOAD

Silhouette InstaLift® in Minimally Invasive Tissue
Repositioning for Facial Rejuvenation

DOWNLOAD
Absorbable sutures with hand-tied knots and bidirectional cones are available in 3 sizes:3
• 8 cones (4 per side)
• 12 cones (6 per side)
• 16 cones (8 per side)

 

BECOME A
PROVIDER

JOIN TODAY

IMPORTANT SAFETY CONSIDERATIONS 


Silhouette InstaLift should not be used in patients with any known allergy or foreign body sensitivities to plastic biomaterial or in situations where internal fixation is otherwise contraindicated, (e.g. infection.) The device should not be used in patients appearing to have very thin soft tissue of the face in which the implant may be visible or palpable. 


Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. Adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction, pain, swelling and edema, transient hematoma or bruising and transient rippling or dimple formation. For more safety information, please consult with your physician and the patient labeling that can be found by visiting our website at www.instalift.com. 


Individual technique and results may vary.


Silhouette lnstaLift® is indicated for use in mid-face suspension surgery to temporarily fixate the cheek sub-dermis in an elevated position.


*A study of 100 patients treated with Silhouette InstaLift. Results were based on patient satisfaction surveys sent at 1 week post-treatment (n=28) and at 3 months posttreatment (n=47). Improvement in midfacial deficits was evaluated by clinical reviewers at 3 and 6 months post-treatment using a volume deficit scale (0=none, 1=minimal, 2=mild, 3=moderate, 4=significant, and 5=severe) (n=91). The majority of patients started with an average deficit of 3.Model is a real patient treated with Silhouette InstaLift by Tam Nguyen, MD. Individual technique and results may vary. †18% PGA/82% PLLA.


References: 1. Silhouette InstaLift® Instructions for Use. Sinclair Pharmaceuticals; 2019., 2. Ulery BD, Nair LS, Laurencin CT. Biomedical applications of biodegradable polymers. J Polym Sci B Polym Phys. 2011;49(12):832-864. 4. Nestor MS, Ablon G, Andriessen A, et al. Expert consensus on absorbable advanced suspension technology for facial tissue repositioning and volume enhancement. J Drugs Dermatol. 2017;16(7):661-666.

 

Important Safety Information

Bellafill®
Bellafill® is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years. Patients who have had a positive reaction to the Bellafill® Skin Test, have a history of severe allergies, have known bovine collagen allergies, are allergic to lidocaine, have bleeding disorders or are prone to thick scar formation and/or excessive scarring should not receive Bellafill®. The safety of Bellafill® for use during pregnancy, breastfeeding, or in patients under 21 has not been established. You may experience temporary swelling, redness, pain, bruising, lumps/bumps, itching, and discoloration at the treatment site. These side effects are usually transient and typically resolve within 1–7 days. You may experience lumps/bumps/papules that may occur more than one month after injection and that may persist. Less common side effects include rash and itching more than 48 hours after treatment, persistent swelling or redness, lumps/bumps, acne, and increased sensitivity at treatment sites. Infrequently, granulomas may occur and may be treated by your licensed physician provider. Be sure to call your licensed provider immediately if you notice any unusual skin reactions around the treatment area. Based on the 5-year Post-Approval Study on nasolabial folds with 1,008 patients, long-term safety of Bellafill® for up to 5 years has been established.

PUREGRAFT
This product is certified as a medical device in the European Union under the Medical Device Directive 93/42/EEC by SGS CE0120, exclusively for the indication of autologous fat transfer. Other non-medical uses ascribed to this device such as aesthetic body contouring are not within the scope of CE certification, and users should be aware product performance and/or safety has not been evaluated by SGS for those purposes.

Suneva Medical HD PRP
REGULATORY STATUS: FDA-cleared 510(k) Class II medical device. Healeon HD PRP is designed to be used for the safe and rapid preparation of autologous platelet-rich-plasma (PRP) from a small sample of peripheral blood at the patient point of care. The PRP is mixed with autograft and/orallograft bone prior to application to a bony defect for improving handling characteristics. 510(k) number: BK170136

Silhouette Instalift
Silhouette lnstaLift® is indicated for use in mid-face suspension surgery to temporarily fixate the cheek sub-dermis in an elevated position.

IMPORTANT SAFETY CONSIDERATIONS
The Silhouette InstaLift device should not be used in patients with any known allergy or foreign body sensitivities to plastic/ biomaterial or in situations where internal fixation is otherwise contraindicated, (e.g. infection.) The device should also not be used in patients appearing to have very thin soft tissue of the face in which the implant may be visible or palpable.

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction, pain (which may be temporary or persistent in nature), swelling and edema, transient hematoma or bruising and transient rippling or dimple formation. For further safety or product information, please consult your physician.

For more safety information, please consult with your physician and the patient labeling that can be found by visiting our website www.bellafill.com.
Toll-free call (U.S. & Canada): 844-Bellafill (844-235-5234).
Local calls: 858-550-9999. International calls: ++ 858-550-9999.